H.B. Fuller Q3 2025 slides: Margin expansion continues despite revenue headwinds

H.B. Fuller (FUL) reported Q3 2025 adjusted EPS of $1.26, exceeding estimates, and a 3% year-over-year increase in adjusted EBITDA to $171 million with significant margin expansion to 19.1%. Despite these profitability gains, net revenue of $892 million missed expectations, and organic revenue declined 0.9% amidst a challenging global economic backdrop, causing an 8.89% premarket stock drop. The company tightened its full-year revenue guidance but raised adjusted EBITDA and EPS forecasts, signaling a strategic focus on margin expansion and operational efficiency to navigate persistent top-line pressures.

Analysis

H.B. Fuller's (FUL) third-quarter 2025 results illustrate a clear divergence between robust profitability and weakening top-line performance. The company successfully expanded its adjusted EBITDA margin by 110 basis points year-over-year to 19.1% and grew adjusted EPS by 12% to $1.26, narrowly beating expectations. This was achieved through effective pricing and raw material management, which also drove a 190-basis-point increase in adjusted gross profit margin to 32.3%. However, these operational successes were overshadowed by a 0.9% decline in organic revenue and a miss on net revenue, which totaled $892 million. The market reacted negatively, with shares falling 8.89% premarket, indicating that investor concerns about the challenging global economic environment and top-line growth are outweighing the company's margin discipline. The revised full-year guidance reinforces this narrative, as FUL now anticipates a net revenue decline of 2-3% but has raised its forecast for adjusted EBITDA to $615-625 million, signaling a strategic focus on defending profitability amidst revenue headwinds. While the balance sheet strengthened with net-debt-to-EBITDA improving to 3.3x, regional weaknesses in EIMEA (-2% organic revenue) and Asia-Pacific (-4%) highlight the persistent external pressures.

Key Decisions for Investors

• Investors should weigh the company's demonstrated ability to expand margins against the persistent revenue headwinds, as the market is currently prioritizing the negative top-line outlook and subdued global economy.
• The upcoming Investor Day on October 20 is a critical catalyst; monitor for management's strategic plan and roadmap to achieving its >20% EBITDA margin target, which could be pivotal for restoring investor confidence.
• Given the stock's significant volatility and a P/E ratio of 31.54, new positions should be considered with caution, as the current valuation may not be fully supported by the flat to slightly negative organic growth profile.
• Scrutinize the performance of the Engineering Adhesives segment, which showed strength with 14% EBITDA growth, as its continued outperformance will be crucial to offsetting weakness in other regions and sectors.